These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 12930633
21. Occult hepatitis B virus infection in Greek patients with chronic hepatitis C and in patients with diverse nonviral hepatic diseases. Georgiadou SP, Zachou K, Rigopoulou E, Liaskos C, Mina P, Gerovasilis F, Makri E, Dalekos GN. J Viral Hepat; 2004 Jul; 11(4):358-65. PubMed ID: 15230859 [Abstract] [Full Text] [Related]
22. Clinical and virological improvement of hepatitis B virus-related or hepatitis C virus-related chronic hepatitis with concomitant hepatitis A virus infection. Sagnelli E, Coppola N, Pisaturo M, Pisapia R, Onofrio M, Sagnelli C, Catuogno A, Scolastico C, Piccinino F, Filippini P. Clin Infect Dis; 2006 Jun 01; 42(11):1536-43. PubMed ID: 16652310 [Abstract] [Full Text] [Related]
23. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission. Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A. Trop Gastroenterol; 2007 Jun 01; 28(1):19-23. PubMed ID: 17896605 [Abstract] [Full Text] [Related]
24. Profile, spectrum and significance of hepatitis B virus genotypes in chronic HBV-infected patients in Yunnan, China. You J, Sriplung H, Chongsuvivatwong V, Geater A, Zhuang L, Huang JH, Chen HY, Yu L, Tang BZ. Hepatobiliary Pancreat Dis Int; 2008 Jun 01; 7(3):271-9. PubMed ID: 18522881 [Abstract] [Full Text] [Related]
25. Lack of impact of hepatitis C virus coinfection in end-stage renal disease patients with hepatitis B virus infection. Moutinho RS, Perez RM, Pace FH, Ferreira AS, Cendoroglo M, Medina-Pestana JO, Lanzoni VP, Silva AE, Ferraz ML. Transplant Proc; 2005 Jun 01; 37(5):2080-2. PubMed ID: 15964344 [Abstract] [Full Text] [Related]
26. Low replication and variability of HBV pre-core in concomitant infection with hepatitis B and hepatitis C viruses. De Mitri MS, Morsica G, Cassini R, Bagaglio S, Andreone P, Bianchi G, Loggi E, Bernardi M. Arch Virol; 2007 Feb 01; 152(2):395-404. PubMed ID: 16953307 [Abstract] [Full Text] [Related]
27. Clinical implications of viral activity in dual infection with hepatitis B and C in chronic liver disease. Guptan RC, Thakur V, Malhotra V, Sarin SK. J Assoc Physicians India; 2002 May 01; 50(5):651-5. PubMed ID: 12186118 [Abstract] [Full Text] [Related]
28. Virological significance of low-level hepatitis B virus infection in patients with hepatitis C virus associated liver disease. Tanaka T, Inoue K, Hayashi Y, Abe A, Tsukiyama-Kohara K, Nuriya H, Aoki Y, Kawaguchi R, Kubota K, Yoshiba M, Koike M, Tanaka S, Kohara M. J Med Virol; 2004 Feb 01; 72(2):223-9. PubMed ID: 14695663 [Abstract] [Full Text] [Related]
29. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy. Chuang WL, Dai CY, Chang WY, Lee LP, Lin ZY, Chen SC, Hsieh MY, Wang LY, Yu ML. Antivir Ther; 2005 Feb 01; 10(1):125-33. PubMed ID: 15751770 [Abstract] [Full Text] [Related]
30. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus]. Wu CH, Xu XY, Tian GS, Yu YY. Zhonghua Yi Xue Za Zhi; 2006 Feb 14; 86(6):390-3. PubMed ID: 16677548 [Abstract] [Full Text] [Related]
31. Prevalence of human cytomegalovirus co-infection in patients with chronic viral hepatitis B and C: a comparison of clinical and histological aspects. Bayram A, Ozkur A, Erkilic S. J Clin Virol; 2009 Jul 14; 45(3):212-7. PubMed ID: 19497785 [Abstract] [Full Text] [Related]
32. Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B. Moutinho RS, Perez RM, Medina-Pestana JO, Figueiredo MS, Koide S, Alberto FL, Silva AE, Ferraz ML. J Med Virol; 2006 Oct 14; 78(10):1284-8. PubMed ID: 16927290 [Abstract] [Full Text] [Related]
33. Virological and clinical aspects of HBV-HCV coinfection in HIV positive patients. Filippini P, Coppola N, Pisapia R, Martini S, Marrocco C, Di Martino F, Sagnelli C, Filippini A, Sagnelli E. J Med Virol; 2007 Nov 14; 79(11):1679-85. PubMed ID: 17854026 [Abstract] [Full Text] [Related]
34. A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin. Yalcin K, Degertekin H, Yildiz F, Kilinc N. J Gastroenterol; 2003 Nov 14; 38(8):796-800. PubMed ID: 14505137 [Abstract] [Full Text] [Related]
35. [An evaluation of the degree of the morphological activity and the stage of the process in patients with chronic liver diseases caused by coinfection with the hepatitis B, C and/or D viruses]. Siutkin VE, Lopatkina TN, Popova IV. Arkh Patol; 1998 Nov 14; 60(6):37-41. PubMed ID: 9949904 [Abstract] [Full Text] [Related]
38. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy. Chehadeh W, Al-Nakib W. J Med Virol; 2009 Apr 14; 81(4):610-8. PubMed ID: 19235842 [Abstract] [Full Text] [Related]
39. Hepatitis B and C viral load changes following initiation of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection. Asmuth DM, Busch MP, Laycock ME, Mohr BA, Kalish LA, van der Horst CM, Viral Activation Transfusion Study (VATS) Group. Antiviral Res; 2004 Aug 14; 63(2):123-31. PubMed ID: 15302141 [Abstract] [Full Text] [Related]
40. Serum adiponectin in chronic hepatitis C and B. Siagris D, Vafiadis G, Michalaki M, Lekkou A, Starakis I, Makri M, Margaritis V, Christofidou M, Tsamandas AC, Labropoulou-Karatza C. J Viral Hepat; 2007 Aug 14; 14(8):577-83. PubMed ID: 17650292 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]